These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 196613)
21. Fluorescence and neutralizing antibodies to herpes simplex virus in the cerebrospinal fluid of patients with central nervous system diseases. Leventon-Kriss S; Rannon L; Joffe R Isr J Med Sci; 1976 Jun; 12(6):553-9. PubMed ID: 182656 [TBL] [Abstract][Full Text] [Related]
23. Type specificity of complement-requiring and immunoglobulin M neutralizing antibody in initial herpes simplex virus infections of humans. Schmidt NJ; Forghani B; Lennette EH Infect Immun; 1975 Oct; 12(4):728-32. PubMed ID: 1193713 [TBL] [Abstract][Full Text] [Related]
24. Enhanced antiglobulin-mediated neutralization of herpes simplex virus-IgG complexes by complement and heterologous anti-immunoglobulin. Shivers JC; Daniels CA Arch Virol; 1979; 59(1-2):89-97. PubMed ID: 218539 [TBL] [Abstract][Full Text] [Related]
25. Immunoglobulin (Ig) G, IgA, and IgA subclass antibodies against fertilization antigen-1 in cervical secretions and sera of women of infertile couples. Menge AC; Naz RK Fertil Steril; 1993 Oct; 60(4):658-63. PubMed ID: 8405520 [TBL] [Abstract][Full Text] [Related]
26. Herpes simplex virus type 2 detection by culture and polymerase chain reaction and relationship to genital symptoms and cervical antibody status during the third trimester of pregnancy. Boggess KA; Watts DH; Hobson AC; Ashley RL; Brown ZA; Corey L Am J Obstet Gynecol; 1997 Feb; 176(2):443-51. PubMed ID: 9065196 [TBL] [Abstract][Full Text] [Related]
28. Studies on the neutralization of herpes simplex virus. X. Demonstration of complement-requiring neutralizing (CRN) and slow-reacting CRN (s-CRN) antibodies in late IgG. Yoshino K; Isono N; Tada A; Urayama M Microbiol Immunol; 1979; 23(10):975-85. PubMed ID: 229389 [TBL] [Abstract][Full Text] [Related]
29. Characterization of Immunoglobulin A/G Responses During 3 Doses of the Human Papillomavirus-16/18 ASO4-Adjuvanted Vaccine. Gonçalves AK; Giraldo PC; Farias KJ; Machado PR; Costa AP; de Souza LC; Crispim JC; Eleutério J; Witkin SS Sex Transm Dis; 2016 May; 43(5):335-9. PubMed ID: 27100772 [TBL] [Abstract][Full Text] [Related]
30. Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement. Nemerow GR; Jensen FC; Cooper NR J Clin Invest; 1982 Nov; 70(5):1081-91. PubMed ID: 6290536 [TBL] [Abstract][Full Text] [Related]
31. Measurement of antibodies to herpesvirus types 1 and 2 in human sera by microradioimmunoassay. Jankowski MA; Petersen EE; Böcker JF Acta Virol; 1977 Sep; 21(5):405-11. PubMed ID: 22235 [TBL] [Abstract][Full Text] [Related]
32. Immune inhibition of virus release from herpes simplex virus-infected cells by human sera. Shariff DM; Hallworth J; Desperbasques M; Buchan A; Skinner GR Intervirology; 1988; 29(3):125-32. PubMed ID: 2846463 [TBL] [Abstract][Full Text] [Related]
33. Class-specific herpes simplex virus antibodies in sera and cervical secretions from patients with cervical neoplasia: a multi-group comparison. Dale GE; Coleman RM; Best JM; Benetato BB; Drew NC; Chinn S; Papacosta AO; Nahmias AJ Epidemiol Infect; 1988 Jun; 100(3):445-65. PubMed ID: 2837405 [TBL] [Abstract][Full Text] [Related]
34. Herpes simplex type 2 neutralization antibodies in patients with cancers of urinary bladder, prostate, and cervix. Lüleci G; Sakizli M; Günalp A; Erkan I; Remzi D J Surg Oncol; 1981; 16(4):327-31. PubMed ID: 6265707 [TBL] [Abstract][Full Text] [Related]
36. Long-term follow-up studies on herpes simplex antibodies in the course of cervical cancer: patterns of neutralizing antibodies. Christenson B; Espmark A Am J Epidemiol; 1977 Apr; 105(4):296-302. PubMed ID: 192072 [TBL] [Abstract][Full Text] [Related]
37. Neutralization of herpes simplex virus by antibody in amniotic fluid. Bradley JS; Yeager AS; Dyson DC; Hensleigh PA; Medearis AL Obstet Gynecol; 1982 Sep; 60(3):318-21. PubMed ID: 6289206 [TBL] [Abstract][Full Text] [Related]
38. Studies on the neutralization of herpes simplex virus. XI. Differences between slow-reacting complement-requiring neutralizing (s-CRN) antibodies in IgG and IgM. Yoshino K; Urayama M; Abe K Microbiol Immunol; 1980; 24(11):1069-77. PubMed ID: 6261091 [TBL] [Abstract][Full Text] [Related]
39. Serum antibodies to herpes simplex virus type 1 during active oral herpes infection. Ratner JJ; Smith KO Infect Immun; 1980 Jan; 27(1):113-7. PubMed ID: 6244224 [TBL] [Abstract][Full Text] [Related]
40. Detection of antibodies of the IgG and IgM classes to herpes simplex virus type 1 in cerebrospinal fluid and serum from four patients with herpes encephalitis. Rapicetta M; Morace G; Alema G; Mancini G Microbiologica; 1984 Jul; 7(3):273-7. PubMed ID: 6094987 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]